Cystic fibrosis year in review 2024

被引：0

作者：

Alameeri, Amel ^{[1
]}

Yavuz, Burcu Capraz ^{[2
]}

Lucca, Francesca ^{[3
]}

Bambir, Ivan ^{[4
]}

Famulska, Paulina ^{[5
]}

Cohen, Renata W. F. ^{[6
]}

机构：

[1] ST Shaikh Tahnoon Med City Hosp, Dept Adult Pulm Med, Al Ain, Abudhabi, U Arab Emirates

[2] Hacettepe Univ, Fac Med, Ihsan Dogramaci Childrens Hosp, Dept Pediat Pulmonol, Ankara, Turkiye

[3] AOUI Verona, Cyst Fibrosis Ctr, Cardiothoracovasc Dept, Verona, Italy

[4] Univ Hosp Ctr Zagreb, Cyst Fibrosis Ctr Peadiatr & Adult Zagreb, Zagreb, Croatia

[5] Polanki Childrens Hosp, Dept Pediat & Cyst Fibrosis, Gdansk, Poland

[6] Inst Fernandes Figueira FIOCRUZ, Pediat Cyst Fibrosis Ctr, Dept Pediat Pulmonol, Rio De Janeiro, RJ, Brazil

来源：

JOURNAL OF CYSTIC FIBROSIS | 2025年 / 24卷 / 02期

关键词：

Cystic fibrosis; CFTR-RELATED DISORDERS; ECFS STANDARDS; MODULATOR USE; ELEXACAFTOR/TEZACAFTOR/IVACAFTOR; CHILDREN; ADULTS; IMPACT; CARE;

D O I：

10.1016/j.jcf.2025.02.012

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

The year 2024 marks a pivotal moment in the field of cystic fibrosis (CF) treatment, characterised by significant advancements in clinical care and an expanding body of literature on CF transmembrane conductance regulator (CFTR) modulators. These CFTR therapies have transformed the landscape of CF management, offered systemic benefits, and established new guidelines for assessing clinical manifestations and therapies. Additionally, progress has been made in newborn screening (NBS), diagnosis, and understanding outcomes for individuals with CF-related metabolic syndrome or inconclusive diagnostic results. However, amidst these clinical milestones, disparities in global access to CFTR modulators (CFTRm) persist, threatening to exacerbate existing inequities in CF care. This review provides a focused overview of the most impactful articles from 2024, highlighting both the clinical advancements and the pressing global accessibility challenges that define this transformative era in CF research and treatment.

引用

页码：218 / 223

页数：6

共 50 条

[41] Bronchial Artery Embolization for Hemoptysis in Cystic Fibrosis Patients: A 17-Year Review
Martin, Lynne N.
Higgins, Luke
Mohabir, Paul
Sze, Daniel Y.
Hofmann, Lawrence, V
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2020, 31 (02) : 331 - 335
[42] THE CANADIAN MARITIME CYSTIC FIBROSIS NEWBORN SCREENING PROGRAM: A 5-YEAR REVIEW
Donnelly, C. A.
Mateos-Corral, D.
PEDIATRIC PULMONOLOGY, 2019, 54 : S239 - S240
[43] Cystic fibrosis year in review 2020: Section 2 pulmonary disease, infections, and inflammation
Antos, Nicholas J.
Savant, Adrienne P.
PEDIATRIC PULMONOLOGY, 2022, 57 (02) : 347 - 360
[44] Neonatal screening for cystic fibrosis in the Oxford genetics laboratory: A review of the first year of testing
Lord, Helen
Williams, L.
Lester, T.
Roberts, A.
Kay, J.
Smith, I.
Thomson, A.
Seller, A.
JOURNAL OF MEDICAL GENETICS, 2007, 44 : S95 - S95
[45] CYSTIC-FIBROSIS IN THE YEAR-2000
ROSENSTEIN, BJ
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 15 (05) : 446 - 451
[46] CYSTIC-FIBROSIS - 11 YEAR SURVEY
OHALLORAN, ET
IRISH MEDICAL JOURNAL, 1978, 71 (06) : 184 - 187
[47] 2024 JCRP Year in Review
Brown, Todd M.
JOURNAL OF CARDIOPULMONARY REHABILITATION AND PREVENTION, 2024, 44 (06) : 383 - 384
[48] Study Review for the Year 2024
Neubauer, Andreas
INNERE MEDIZIN, 2025, 66 (02):
[49] LUNG Year in Review: 2024
Dicpinigaitis, Peter V.
LUNG, 2025, 203 (01)
[50] SPN 2024 Year in Review
Baird, Jennifer
JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES, 2025, 80 : 177 - 179

← 1 2 3 4 5 →